158 related articles for article (PubMed ID: 8982949)
21. Phytanic acid alpha-oxidation: accumulation of 2-hydroxyphytanic acid and absence of 2-oxophytanic acid in plasma from patients with peroxisomal disorders.
ten Brink HJ; Schor DS; Kok RM; Poll-The BT; Wanders RJ; Jakobs C
J Lipid Res; 1992 Oct; 33(10):1449-57. PubMed ID: 1385561
[TBL] [Abstract][Full Text] [Related]
22. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
[TBL] [Abstract][Full Text] [Related]
23. Infantile phytanic acid storage disease, a disorder of peroxisome biogenesis: a case report.
Wanders RJ; Boltshauser E; Steinmann B; Spycher MA; Schutgens RB; van den Bosch H; Tager JM
J Neurol Sci; 1990 Aug; 98(1):1-11. PubMed ID: 1700075
[TBL] [Abstract][Full Text] [Related]
24. Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction.
Poll-The BT; Saudubray JM; Ogier H; Schutgens RB; Wanders RJ; Schrakamp G; van den Bosch H; Trijbels JM; Poulos A; Moser HW
J Inherit Metab Dis; 1986; 9(2):169-74. PubMed ID: 2427795
[TBL] [Abstract][Full Text] [Related]
25. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentography.
ten Brink HJ; Stellaard F; van den Heuvel CM; Kok RM; Schor DS; Wanders RJ; Jakobs C
J Lipid Res; 1992 Jan; 33(1):41-7. PubMed ID: 1372637
[TBL] [Abstract][Full Text] [Related]
26. Measurement of very long-chain fatty acids, phytanic and pristanic acid in plasma and cultured fibroblasts by gas chromatography.
Dacremont G; Cocquyt G; Vincent G
J Inherit Metab Dis; 1995; 18 Suppl 1():76-83. PubMed ID: 9053557
[TBL] [Abstract][Full Text] [Related]
27. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
Van Veldhoven PP; Huang S; Eyssen HJ; Mannaerts GP
J Inherit Metab Dis; 1993; 16(2):381-91. PubMed ID: 7692128
[TBL] [Abstract][Full Text] [Related]
28. Reinvestigation of trihydroxycholestanoic acidemia reveals a peroxisome biogenesis disorder.
Gootjes J; Skovby F; Christensen E; Wanders RJ; Ferdinandusse S
Neurology; 2004 Jun; 62(11):2077-81. PubMed ID: 15184617
[TBL] [Abstract][Full Text] [Related]
29. Zellweger syndrome: biochemical procedures in diagnosis, prevention and treatment.
Schutgens RB; Wanders RJ; Heymans HS; Schram AW; Tager JM; Schrakamp G; van den Bosch H
J Inherit Metab Dis; 1987; 10 Suppl 1():33-45. PubMed ID: 3119940
[TBL] [Abstract][Full Text] [Related]
30. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.
Reddy JK; Hashimoto T
Annu Rev Nutr; 2001; 21():193-230. PubMed ID: 11375435
[TBL] [Abstract][Full Text] [Related]
31. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
Street JM; Singh H; Poulos A
Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
[TBL] [Abstract][Full Text] [Related]
32. Pristanic acid and phytanic acid in plasma from patients with a single peroxisomal enzyme deficiency.
ten Brink HJ; Wanders RJ; Stellaard F; Schutgens RB; Jakobs C
J Inherit Metab Dis; 1991; 14(3):345-8. PubMed ID: 1722861
[No Abstract] [Full Text] [Related]
33. Quantification of Very-Long-Chain and Branched-Chain Fatty Acids in Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
De Biase I; Pasquali M
Methods Mol Biol; 2022; 2546():509-521. PubMed ID: 36127618
[TBL] [Abstract][Full Text] [Related]
34. Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig-Hoffmann disease.
Baumgartner MR; Verhoeven NM; Jakobs C; Roels F; Espeel M; Martinez M; Rabier D; Wanders RJ; Saudubray JM
Neurology; 1998 Nov; 51(5):1427-32. PubMed ID: 9818873
[TBL] [Abstract][Full Text] [Related]
35. A sibship with a mild variant of Zellweger syndrome.
Barth PG; Schutgens RB; Wanders RJ; Heymans HS; Moser AE; Moser HW; Bleeker-Wagemakers EM; Jansonius-Schultheiss K; Derix M; Nelck GF
J Inherit Metab Dis; 1987; 10(3):253-9. PubMed ID: 3123783
[TBL] [Abstract][Full Text] [Related]
36. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata.
Schutgens RB; Bouman IW; Nijenhuis AA; Wanders RJ; Frumau ME
Clin Chem; 1993 Aug; 39(8):1632-7. PubMed ID: 8353949
[TBL] [Abstract][Full Text] [Related]
37. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders.
Takemoto Y; Suzuki Y; Horibe R; Shimozawa N; Wanders RJ; Kondo N
Brain Dev; 2003 Oct; 25(7):481-7. PubMed ID: 13129591
[TBL] [Abstract][Full Text] [Related]
38. Phytanic acid alpha-oxidation in peroxisomal disorders: studies in cultured human fibroblasts.
Verhoeven NM; Schor DS; Roe CR; Wanders RJ; Jakobs C
Biochim Biophys Acta; 1997 Oct; 1361(3):281-6. PubMed ID: 9375802
[TBL] [Abstract][Full Text] [Related]
39. Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism.
Blankestijn M; Bloks VW; Struik D; Huijkman N; Kloosterhuis N; Wolters JC; Wanders RJA; Vaz FM; Islinger M; Kuipers F; van de Sluis B; Groen AK; Verkade HJ; Jonker JW
Sci Rep; 2022 Feb; 12(1):2512. PubMed ID: 35169201
[TBL] [Abstract][Full Text] [Related]
40. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
